Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation.

The biological mechanism underlying steroid therapy for treating keloids remains unclear. Analytical results demonstrated that topical intra-lesional steroid injections suppress vascular endothelial growth factor (VEGF) expression in keloid tissue and induce its regression in vivo. This study investigated whether glucocorticoid (dexamethasone) downregulates VEGF expression and hinders keloid fibroblast (KF) proliferation in keloid regression. Primary KF cultures were treated with various concentrations of dexamethasone, glucocorticoid receptor (GR) antagonist (mifeprostone, RU-486), VEGF-A antibody, VEGF receptor-2 (VEGF-R2) antagonist (SU-5416), and VEGF protein. Analytical results demonstrated that dexamethasone retarded KFs proliferation. However, suppression of fibroblast proliferation by dexamethasone pre-treatment was reduced by adding exogenous VEGF protein. Dexamethasone suppressed endogenous VEGF mRNA induction, protein expressed by KFs, and angiogenesis activity detected by a tube-forming assay of human umbilical vein endothelial cells co-cultured fibroblasts. These effects were reversed by pre-treatment with RU-486, and not by pre-treatment with SU-5416. Thus, dexamethasone induces keloid regression via interaction with the GR and suppresses endogenous VEGF expression and fibroblast proliferation. However, exogenous VEGF promotes fibroblast proliferation through the GR-independent pathway. Modulation of VEGF production may comprise a valuable treatment modality for keloids.

[1]  D. Herndon,et al.  Altered cytokine production in black patients with keloids , 1992, Journal of Clinical Immunology.

[2]  J. Arbiser,et al.  Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor. , 2004, Journal of the American Academy of Dermatology.

[3]  D. Messadi,et al.  Elevated Vascular Endothelial Growth Factor in Keloids: Relevance to Tissue Fibrosis , 2004, Cells Tissues Organs.

[4]  J. P. Watson,et al.  Downregulation of apoptosis-related genes in keloid tissues. , 1999, The Journal of surgical research.

[5]  M. Hanasono,et al.  Triamcinolone Stimulates bFGF Production and Inhibits TGF‐β1 Production by Human Dermal Fibroblasts , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[6]  I. K. Cohen,et al.  The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. , 1996, Plastic and reconstructive surgery.

[7]  G. Schultz,et al.  Growth factors and wound healing: biochemical properties of growth factors and their receptors. , 1993, American journal of surgery.

[8]  J. Kiil.  Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results. , 1977, Scandinavian journal of plastic and reconstructive surgery.

[9]  I. K. Cohen,et al.  Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro , 1979, Journal of cellular physiology.

[10]  B. S. Reddy.  Intralesional 5‐Fluorouracil as a Treatment Modality of Keloids , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[11]  K. Thomas.  Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent (*) , 1996, The Journal of Biological Chemistry.

[12]  Susan C. Taylor,et al.  Keloidal scars: a review with a critical look at therapeutic options. , 2002, Journal of the American Academy of Dermatology.

[13]  N. Ferrara,et al.  Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.

[14]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[15]  S. Pollack,et al.  The surgical treatment of keloids. , 1982, The Journal of dermatologic surgery and oncology.

[16]  M. Franka,et al.  Treatment of Earlobe Keloids Using the Cobalt 60 Teletherapy Unit , 2004, Annals of plastic surgery.

[17]  R. Wb,et al.  Keloids and hypertrophic scars: a comprehensive review. , 1989, Plastic and reconstructive surgery.

[18]  S. Jeng,et al.  Activation of ERK and p38 kinase mediated keloid fibroblast apoptosis after flashlamp pulsed‐dye laser treatment , 2005, Lasers in surgery and medicine.

[19]  C. Boyadjiev,et al.  Histomorphologic changes in keloids treated with Kenacort. , 1995, The Journal of trauma.

[20]  H. Xue,et al.  Elevated interleukin-6 expression in keloid fibroblasts. , 2000, The Journal of surgical research.

[21]  J. Murray,et al.  Keloids and Hypertrophic Scars , 2015 .

[22]  Seng H. Cheng,et al.  Hypoxia-Inducible Factor-1 Mediates Activation of Cultured Vascular Endothelial Cells by Inducing Multiple Angiogenic Factors , 2003, Circulation research.

[23]  M. Longaker,et al.  Hypoxia upregulates VEGF production in keloid fibroblasts. , 1999, Annals of plastic surgery.

[24]  D. Ann,et al.  Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. , 2004, American journal of physiology. Cell physiology.

[25]  C. Zouboulis,et al.  Current developments and uses of cryosurgery in the treatment of keloids and hypertrophic scars , 2002 .

[26]  L. Borgognoni.  Biological effects of silicone gel sheeting , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[27]  J. Russell,et al.  Glucocorticoid receptors in human fibroblasts derived from normal dermis and keloid tissue. , 1984, The Journal of biological chemistry.

[28]  D. Willoughby,et al.  Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. , 1996, The American journal of pathology.

[29]  S. Jeng,et al.  Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down‐regulation of TGF‐β1 expression and extracellular matrix expression , 2004, Lasers in surgery and medicine.

[30]  T. K. Hunt,et al.  Transforming growth factor beta (TGF-beta) and dexamethasone have direct opposing effects on collagen metabolism in low passage human dermal fibroblasts in vitro. , 1994, Growth factors.